Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$461.12 USD
+6.11 (1.34%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $459.58 -1.54 (-0.33%) 7:58 PM ET
1-Strong Buy of 5 1
D Value D Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$461.12 USD
+6.11 (1.34%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $459.58 -1.54 (-0.33%) 7:58 PM ET
1-Strong Buy of 5 1
D Value D Growth A Momentum D VGM
Zacks News
Intuitive Surgical Hits 52-Week High on Multiple Positives
by Zacks Equity Research
Shares of leading provider of robotic-assisted surgery, Intuitive Surgical, Inc. (ISRG) rallied to a new 52-week high of $770.28 on Mar 28, closing a tad lower at $764.47.
Intuitive Surgical (ISRG) Beats on Q4 Earnings & Revenues
by Zacks Equity Research
Intuitive Surgical Inc. (ISRG) posted adjusted earnings of $5.30 per share in the fourth quarter of 2016, beating the Zacks Consensus Estimate by four cents.
Should You Buy Intuitive Surgical (ISRG) Ahead of Earnings?
by Zacks Equity Research
Intuitive Surgical (ISRG) looks like an exciting pick for investors as it is poised to beat at earnings season.
Medical Product Stocks Q4 Earnings Roster: SYK, ISRG, RMD
by Zacks Equity Research
Medical is one of the broader sectors among the 16 Zacks sectors that is expected to report earnings growth in the fourth quarter.
The Zacks Analyst Blog Highlights: Intuitive Surgical, Stryker and Hologic
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Intuitive Surgical, Stryker and Hologic
Is Earnings Beat Likely for Intuitive Surgical (ISRG) in Q4?
by Zacks Equity Research
We expect Intuitive Surgical Inc (ISRG) to beat earnings expectations when it reports fourth-quarter 2016 and full-year results on Jan 24.
3 Medical Device Stocks Likely to Beat Earnings Estimates
by Zacks Equity Research
The likely revocation of the 2.3% medical device excise tax is going to be a big bonus for both the behemoths and small players.
Intuitive Surgical (ISRG) Expects Strong Revenues in Q4
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) announced that it expects fourth-quarter 2016 revenues of approximately $757 million.
Intuitive Surgical (ISRG) Raises Share Buyback to $3 Billion
by Zacks Equity Research
Intuitive Surgical Inc. (ISRG) increased the authorized amount available under the company's share repurchase program to $3.0 billion.
New Strong Buy Stocks for November 9th
by Indradip Ghosh
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
New Stock Research Reports for June 23, 2016
by Sheraz Mian
Today's must-read reports are for IBM (IBM), General Motors Company (GM) and MetLife, Inc. (MET).
4 Medical Instrument Makers to Save Your Portfolio
by Jeremy Mullin
Technology in the medical world is leading these companies to breakthrough devices, which save and extend lives.
How to Pick Winning Stocks When the Market is Going Down
by Kevin Matras
Kevin Matras goes over a Relative Price Change screen to help you find top performers no matter what the market is doing. Highlighted stocks include CPB, TAST, ISRG, VCRA and BRKR.